Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Identiv Sees Q2 Sales $4.900M-$5.300M vs $5.20M Est

Author: Benzinga Newsdesk | May 07, 2025 03:17pm
Identiv (NASDAQ:INVE) sees Q2 sales of $4.900 million-$5.300 million vs $5.20 million analyst estimate.

Posted In: INVE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist